Anti-inflammatory activity of a novel lectin isolated from Pleurotus eryngii var. ferulae mushroom
Thoiba Mogahid Hussein Seliman, Gülsüm Altıparmak Ülbegi, Nurten Özsoy, Hevidar Alp Kavlo, Pınar Aksoy SağırlıBackground and Aims: Pleurotus species are edible mushrooms with important economic and medicinal value. Many phar macological properties of these species, such as anticancer, immunomodulating, and anti-inflammatory activities, have been attributed to lectin. The aim of this study was to purify a novel lectin from Pleurotus eryngii var. ferulae (PEFL) and investigate its anti-inflammatory activity.
Methods:PEFLwaspurifiedby80%ammoniumsulphatefractionation,diethylaminoethyl(DEAE)-Sepharose-4Banionexchange, and Sephadex G-100 gel filtration chromatography. The molar mass of the purified lectin was determined by sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) under denaturing conditions. Inhibition of lectin-induced haemagglu tination by several carbohydrates and one glycoprotein (ovalbumin) was also performed using the haemagglutination inhibition activity test. The anti-inflammatory effect of PEFL was tested in a lipopolysaccharide (LPS)-induced inflammation model in mouse macrophage cells (RAW 264.7). The levels of prostaglandin (PG)-E2, tumour necrosis factor-alpha (TNF-𝛼), interleukin 1-beta (IL-1𝛽), interleukin-6 (IL-6), interleukin-10 (IL-10), and interferon-gamma (IFN-𝛾) were determined using enzyme-linked immunosorbent assay (ELISA) kits. Furthermore, the expression of nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) was estimated by western blot analysis.
Results: PEFL wasobtained in 16%yield. The specific activity of PEFL was calculated as 1280 haemagglutinating units (HU)/mg protein and was inhibited only by D-galactose. The molecular weight was determined to be 46 kDa. PEFL showed an anti inflammatory effect by reducing the production of pro-inflammatory PGs through COX-2 inhibition, as well as reducing iNOS expression. Furthermore, our findings reported that PEFL has a protective effect on inflammation by decreasing the production of pro-inflammatory cytokines and increasing the production of the anti-inflammatory cytokine (IL-10).
Conclusion:TheresultssuggestthatPEFLcanbeconsideredasapotentialtherapeuticagentinthedevelopmentofnewtherapeutic strategies for inflammatory diseases.